Renin-angiotensin system blockers and susceptibility to COVID-19: an international, open science, cohort analysis. Morales, D. R., Conover, M. M., You, S. C., Pratt, N., Kostka, K., Duarte-Salles, T., Fernandez-Bertolin, S., Aragon, M., DuVall, S. L., Lynch, K., Falconer, T., van Bochove, K., Sung, C., Matheny, M. E., Lambert, C. G., Nyberg, F., Alshammari, T. M., Williams, A. E., Park, R. W., Weaver, J., Sena, A. G., Schuemie, M. J., Rijnbeek, P. R., Williams, R. D., Lane, J. C. E., Prats-Uribe, A., Zhang, L., Areia, C., Krumholz, H. M., Prieto-Alhambra, D., Ryan, P. B., Hripcsak, G., & Suchard, M. A. Lancet Digit Health, 3(2):e98-e114, 2021.
Renin-angiotensin system blockers and susceptibility to COVID-19: an international, open science, cohort analysis [pdf]Paper  doi  bibtex   

Downloads: 0